CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

Nature Communications

May 26, 2020

10.1038/s41467-020-16393-4

Cited by 219

Related Papers

No related papers found

Powered by citation graph analysis